データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
ResMed Shares Are Trading Lower After Rival Eli Lilly Received Approval for Zepbound as an Obstructive Sleep Apnea Treatment for Obese Adults.
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
Financial Crime Weekly: Becton, Dickinson And Co. Pays $175 Million Penalty, Express Fails To Disclose CEO's Full Compensation
Boston Scientific Updates Instructions for Cryoablation Balloons After Reports Of Severe Injuries
J.P. Morgan's Top Healthcare Stocks for 2025